These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 26633383

  • 1. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
    Yang J, Cheng D, Zhou S, Zhu B, Hu T, Yang Q.
    Int J Mol Sci; 2015 Dec 02; 16(12):28635-46. PubMed ID: 26633383
    [Abstract] [Full Text] [Related]

  • 2. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
    Zhu B, Cheng D, Li S, Zhou S, Yang Q.
    Int J Mol Sci; 2016 Jul 22; 17(7):. PubMed ID: 27455247
    [Abstract] [Full Text] [Related]

  • 3. Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma.
    Li G, Cai M, Fu D, Chen K, Sun M, Cai Z, Cheng B.
    Cell Physiol Biochem; 2012 Jul 22; 30(6):1481-90. PubMed ID: 23208072
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
    Li X, Xu R, Liu H, Fang K.
    Tumour Biol; 2016 Jun 22; 37(6):8139-44. PubMed ID: 26715273
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cyclin L1 participates in Adriamycin resistance and progression of osteosarcoma via PI3K/AKT-mTOR pathway.
    Zhang Y, Zhang T, Chen L, Guo Z, Jiang X.
    Aging (Albany NY); 2024 Jun 26; 16(14):11208-11223. PubMed ID: 39024509
    [Abstract] [Full Text] [Related]

  • 12. A novel chemical, STF-083010, reverses tamoxifen-related drug resistance in breast cancer by inhibiting IRE1/XBP1.
    Ming J, Ruan S, Wang M, Ye D, Fan N, Meng Q, Tian B, Huang T.
    Oncotarget; 2015 Dec 01; 6(38):40692-703. PubMed ID: 26517687
    [Abstract] [Full Text] [Related]

  • 13. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
    He R, Wu JX, Zhang Y, Che H, Yang L.
    Eur Rev Med Pharmacol Sci; 2018 Sep 01; 22(18):5857-5866. PubMed ID: 30280767
    [Abstract] [Full Text] [Related]

  • 14. Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor-κB pathway.
    Zhang CL, Wang C, Yan WJ, Gao R, Li YH, Zhou XH.
    Oncol Rep; 2014 Sep 01; 32(3):1149-55. PubMed ID: 24969828
    [Abstract] [Full Text] [Related]

  • 15. GDF15 promotes osteosarcoma cell migration and invasion by regulating the TGF‑β signaling pathway.
    Chen G, Wang M, Liu X.
    Mol Med Rep; 2019 Nov 01; 20(5):4262-4270. PubMed ID: 31545486
    [Abstract] [Full Text] [Related]

  • 16. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y, Cheng H, Li W, Wu H, Yang Y.
    Int J Cancer; 2019 Aug 15; 145(4):1068-1082. PubMed ID: 30761524
    [Abstract] [Full Text] [Related]

  • 17. TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway.
    Xu G, Guo Y, Xu D, Wang Y, Shen Y, Wang F, Lv Y, Song F, Jiang D, Zhang Y, Lou Y, Meng Y, Yang Y, Kang Y.
    Sci Rep; 2017 Feb 16; 7():42411. PubMed ID: 28205534
    [Abstract] [Full Text] [Related]

  • 18. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
    Zhou XH, Yang CQ, Zhang CL, Gao Y, Yuan HB, Wang C.
    Oncol Rep; 2014 Oct 16; 32(4):1505-12. PubMed ID: 25109282
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
    Qiu Q, Jiang J, Lin L, Cheng S, Xin D, Jiang W, Shen J, Hu Z.
    Int J Oncol; 2016 Jun 16; 48(6):2508-20. PubMed ID: 27082640
    [Abstract] [Full Text] [Related]

  • 20. LHX2 promotes malignancy and inhibits autophagy via mTOR in osteosarcoma and is negatively regulated by miR-129-5p.
    Song H, Liu J, Wu X, Zhou Y, Chen X, Chen J, Deng K, Mao C, Huang S, Liu Z.
    Aging (Albany NY); 2019 Nov 13; 11(21):9794-9810. PubMed ID: 31724536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.